The Louisiana Department of Health and Hospitals says four new cases of West Nile virus bring this year's total to 14.
It says the new cases include the year's third nervous system infection — the infection's most dangerous form. That patient is in St. Tammany Parish; earlier neuroinvasive cases were reported in Rapides and Vernon parishes.
The other new cases were in Bossier and East and West Baton Rouge parishes. They include one patient with flu-like West Nile fever and two people without symptoms, found in blood donor screening.
Dr. Lisa Sterman holds up a Truvada pill at her office in San Francisco in May. Even before the Food and Drug Administration's approval, Sterman had prescribed Truvada for about a dozen patients at high risk for developing AIDS.
The Food and Drug Administration has given the first OK for a drug to prevent HIV infection.
The daily pill Truvada, made by Gilead Sciences, combines two medicines that inhibit the reproduction of HIV. It's been a mainstay in the treatment of HIV/AIDS for years, and as of today is an approved option for reducing the risk of HIV infection for people at high risk.
Health care providers and patients who rely on Louisiana's Medicaid program are expected to learn Friday how the Jindal administration plans to slash $859 million in the program that takes care of the poor, elderly and disabled.
The cuts are tied to a congressional reduction in Louisiana's federal Medicaid financing rate.
The reductions will strip 11 percent of the funding from the $7.7 billion Medicaid budget that lawmakers passed for the fiscal year that began July 1.